These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11990495)

  • 1. Increased release of glucuronoxylomannan antigen and induced phenotypic changes in Trichosporon asahii by repeated passage in mice.
    Karashima R; Yamakami Y; Yamagata E; Tokimatsu I; Hiramatsu K; Nasu M
    J Med Microbiol; 2002 May; 51(5):423-432. PubMed ID: 11990495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan.
    Fonseca FL; Frases S; Casadevall A; Fischman-Gompertz O; Nimrichter L; Rodrigues ML
    Fungal Genet Biol; 2009; 46(6-7):496-505. PubMed ID: 19285564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glucuronoxylomannan-like glycan produced by Trichosporon mucoides.
    Zimbres ACG; Albuquerque PC; Joffe LS; Souza TN; Nimrichter L; Frazão SO; Albuquerque P; Fonseca FL; Rodrigues ML
    Fungal Genet Biol; 2018 Dec; 121():46-55. PubMed ID: 30268928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
    Martinez LR; Moussai D; Casadevall A
    Infect Immun; 2004 Jun; 72(6):3674-9. PubMed ID: 15155683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of Secreted Carbohydrates that Present Immunologic Similarities with the Cryptococcus Glucuronoxylomannan by Members of the Trichosporonaceae Family: A Comparative Study Among Species of Clinical Interest.
    de Andrade IB; Almeida MA; Figueiredo-Carvalho MHG; Coelho RA; Chaves ALDS; Frases S; Zancopé-Oliveira RM; Brito-Santos F; Almeida-Paes R
    Mycopathologia; 2021 Jun; 186(3):377-385. PubMed ID: 33956292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic switching and beta-N-acetylhexosaminidase activity of the pathogenic yeast Trichosporon asahii.
    Ichikawa T; Sugita T; Wang L; Yokoyama K; Nishimura K; Nishikawa A
    Microbiol Immunol; 2004; 48(4):237-42. PubMed ID: 15107533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching of colony morphology and adhesion activity of Trichosporon asahii clinical isolates.
    Ichikawa T; Yoshiyama N; Ohgane Y; Ikeda R
    Med Mycol; 2016 Feb; 54(2):189-96. PubMed ID: 26483434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
    Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
    Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity.
    Lyman CA; Devi SJ; Nathanson J; Frasch CE; Pizzo PA; Walsh TJ
    J Clin Microbiol; 1995 Jan; 33(1):126-30. PubMed ID: 7535310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
    May RJ; Beenhouwer DO; Scharff MD
    J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
    Beenhouwer DO; May RJ; Valadon P; Scharff MD
    J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of the emerging human pathogens Trichosporon asahii and Trichosporon asteroides from other pathogenic yeasts and moulds by using species-specific monoclonal antibodies.
    Davies GE; Thornton CR
    PLoS One; 2014; 9(1):e84789. PubMed ID: 24392156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.
    Retini C; Kozel TR; Pietrella D; Monari C; Bistoni F; Vecchiarelli A
    Infect Immun; 2001 Oct; 69(10):6064-73. PubMed ID: 11553544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen.
    Lyman CA; Garrett KF; Pizzo PA; Walsh TJ
    J Infect Dis; 1994 Dec; 170(6):1557-65. PubMed ID: 7995996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii.
    Sasaki E; Tashiro T; Kuroki M; Seki M; Miyazaki Y; Maesaki S; Tomono K; Kadota J; Kohno S
    Clin Exp Immunol; 2000 Feb; 119(2):293-8. PubMed ID: 10632665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichosporon asahii secretes a 30-kDa aspartic peptidase.
    Valle RS; Ramos LS; Reis VJ; Ziccardi M; Dornelas-Ribeiro M; Sodré CL; Branquinha MH; Santos ALS
    Microbiol Res; 2017 Dec; 205():66-72. PubMed ID: 28942846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
    Rodríguez Sánchez H; Pupo Antúnez M; Ilnait MT; Otero A; Martínez Machín G
    Rev Cubana Med Trop; 2005; 57(2):162-4. PubMed ID: 17966590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
    Yauch LE; Lam JS; Levitz SM
    PLoS Pathog; 2006 Nov; 2(11):e120. PubMed ID: 17096589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.
    McFadden DC; Casadevall A
    J Immunol; 2004 Mar; 172(6):3670-7. PubMed ID: 15004170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
    Fleuridor R; Lees A; Pirofski L
    J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.